NEWS – Ovarian Cancer 101
NEWS 2017-09-21T19:47:34+00:00
  • Innovation’s Kevetrin Shows Promising Results in Trial for Late-stage Ovarian Cancer
    by admin on February 21, 2018 at 4:00 pm

    This post was originally published on this site A Phase 2a trial testing Innovation Pharmaceuticals’ p53 modulator Kevetrin as a treatment for late-stage ovarian cancer has been completed, the company announced. The study showed positive anti-cancer results, supporting the development of an oral formulation of the investigational therapy. Kevetrin is a small-molecule activator of p53, a key protein across […] The post Innovation’s Kevetrin Shows Promising Results in Trial for Late-stage Ovarian Cancer appeared first on BioNewsFeeds. […]

  • Ovarian Cancer Screening Too Limited to Aid Women with No Genetic Risk, US Group Says in Policy Update
    by admin on February 19, 2018 at 2:00 pm

    This post was originally published on this site Women who show no symptoms and have no known hereditary risk for ovarian cancer should skip screening for this cancer, a U.S. task force now recommends.  The U.S. Preventive Services Task Force (USPSTF) made the recommendation in “Screening for Ovarian Cancer,” a “statement” published in The Journal […] The post Ovarian Cancer Screening Too Limited to Aid Women with No Genetic Risk, US Group Says in Policy Update appeared first on BioNewsFeeds. […]

  • Early Access to Palliative Care Improves Quality of Life of Terminal Cancer Patients
    by admin on February 16, 2018 at 6:00 pm

    This post was originally published on this site Early access to palliative care significantly enhances the quality of life of advanced cancer patients in their final stages, British researchers reported. Palliative care focuses on the whole person, not just their disease, providing relief from pain and the other symptoms and stress of a serious illness. […] The post Early Access to Palliative Care Improves Quality of Life of Terminal Cancer Patients appeared first on BioNewsFeeds. […]

  • Genetic Discovery May Be ‘Super Assassin’ of Tumor Cells, Researcher Says
    by admin on February 14, 2018 at 1:30 pm

    This post was originally published on this site The nucleotide expansions that cause a number of degenerative diseases may be the reason why these patients are far less susceptible to cancer, a new study suggests. A leading researcher says this discovery represents a “a super assassin against all tumor cells,” including those in ovarian cancer. Researchers […] The post Genetic Discovery May Be ‘Super Assassin’ of Tumor Cells, Researcher Says appeared first on BioNewsFeeds. […]

  • Bright Light Therapy Improves Sleep Quality in Cancer Survivors, Pilot Study Shows
    by admin on February 12, 2018 at 6:00 pm

    This post was originally published on this site Daily sessions of bright light exposure improve sleep quality in fatigued cancer survivors, researchers found. The study, “The Effect of Systematic Light Exposure on Sleep in a Mixed Group of Fatigued Cancer Survivors,” appeared in the Journal of Clinical Sleep Medicine. Cancer patients, including those with ovarian cancer, […] The post Bright Light Therapy Improves Sleep Quality in Cancer Survivors, Pilot Study Shows appeared first on BioNewsFeeds. […]

  • Prexasertib Shrinks Ovarian Cancer Tumors in a Third of Phase 2 Trial Participants
    by admin on February 9, 2018 at 3:20 pm

    This post was originally published on this site The DNA repair inhibitor prexasertib shrank the tumors of a third of the ovarian cancer patients treated with it in a Phase 2 clinical trial, preliminary results show. Its developer, Eli Lilly, said the participants had recurring cancer that failed to respond to platinum-based chemotherapy. The specific form […] The post Prexasertib Shrinks Ovarian Cancer Tumors in a Third of Phase 2 Trial Participants appeared first on BioNewsFeeds. […]

  • Antidepressant Use Does Not Increase Epithelial Ovarian Cancer Risk, Analysis Reveals
    by admin on February 7, 2018 at 2:30 pm

    This post was originally published on this site Women taking antidepressants are not at increased risk for epithelial ovarian cancer, according to a large-scale analysis of eight studies. While a combination of multiple studies is the best approach to determine an association, authors of the paper, “Association between antidepressant medication use and epithelial ovarian cancer risk: […] The post Antidepressant Use Does Not Increase Epithelial Ovarian Cancer Risk, Analysis Reveals appeared first on BioNewsFeeds. […]

  • First Patient Dosed in Phase 3 Trial Testing VB-111 in Platinum-resistant Ovarian Cancer
    by admin on February 5, 2018 at 9:02 pm

    This post was originally published on this site VBL Therapeutics has successfully administered the initial dose to the first patient in its Phase 3 trial investigating the effects of VB-111 (ofranergene obadenovec) in platinum-resistant ovarian cancer. The pivotal OVAL trial (NCT03398655), currently recruiting adult patients, will compare the effectiveness of VB-111 and Taxol (paclitaxel) against Taxol […] The post First Patient Dosed in Phase 3 Trial Testing VB-111 in Platinum-resistant Ovarian Cancer appeared first on BioNewsFeeds. […]

  • ‘Warm’ Chemo Given Ovarian Cancer Patients Seen to Delay Recurrence in Phase 3 Trial
    by admin on February 2, 2018 at 7:34 pm

    This post was originally published on this site Results from a recent phase 3 clinical trial show that a specialized type of chemotherapy delivery may delay disease recurrence in newly diagnosed, advanced ovarian cancer patients. The specialized technique, called hyperthermic intraperitoneal chemotherapy (HIPEC), involves warming the chemotherapy to temperatures greater than 42.0°C (107.6°F) and circulating it […] The post ‘Warm’ Chemo Given Ovarian Cancer Patients Seen to Delay Recurrence in Phase 3 Trial appeared first on BioNewsFeeds. […]

  • Compounds Found to Reverse Chemotherapy Resistance in Ovarian Cancer in Lab Tests
    by Magdalena Kegel on January 31, 2018 at 4:13 pm

    This post was originally published on this site A research team at Southern Methodist University (SMU) in Dallas, Texas, has identified three compounds that were able to reverse resistance to chemotherapy in ovarian tumors. In lab experiments based on calculations from a supercomputer at SMU, multi-drug-resistant ovarian cancer cells died when treated with common chemotherapies and […] The post Compounds Found to Reverse Chemotherapy Resistance in Ovarian Cancer in Lab Tests appeared first on BioNewsFeeds. […]

0